ERcast: Clinical Perspectives Podcast Preview

Subscription Required

A World Without Ondansetron

Andy Little, DO and Zack Repanshek, MD

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Nausea and vomiting are not one syndrome: GI, vestibular, chemoreceptor-trigger-zone, and brain-gut axis patterns respond to different receptor targets. When ondansetron is unavailable or not ideal, matching the antiemetic to the physiology is often more useful than reflexively reaching for a single drug.

Cause-Directed Antiemetic Selection

  • Four emesis phenotypes: A practical four-bucket model—gastrointestinal, vestibular, brainstem, and brain-gut axis—helps match antiemetics to the dominant receptor biology instead of treating all vomiting as the same problem.
  • Gastrointestinal pathway targeting: GI vomiting reflects vagal activation plus serotonin and dopamine signaling, so ondansetron and metoclopramide are common first-line choices, with prochlorperazine as another option.
  • Vestibular mechanism focus: Vertigo-driven nausea is a histamine and muscarinic problem, making meclizine, diphenhydramine, and scopolamine better fits than serotonin-first strategies.
  • Brainstem trigger zone: Chemoreceptor trigger zone nausea from toxins, medications, DKA, or hyperemesis gravidarum involves mixed dopamine, serotonin, histamine, and muscarinic input; trimethobenzamide is a useful alternative with less QT concern.
  • Brain-gut axis syndromes: Cyclic vomiting and related syndromes behave more like central sensitization states, where haloperidol, droperidol, or olanzapine may outperform routine ondansetron. We get into the bedside pattern recognition in the episode.
  • Bridge therapy pearl: Isopropyl alcohol swabs can provide fast bedside relief while IV access is being obtained, a low-tech move that is easy to forget in busy ED nausea care.

Safety Pearls and QT Risk

  • No routine pre-dose EKG: Routine EKG screening before antiemetics is unnecessary in low-risk patients; a quick chart review for long QT history, electrolyte problems, or interacting drugs is usually enough.
  • Medication risk review: Antipsychotics, antiarrhythmics, macrolides, fluoroquinolones, antidepressants, methadone, and other antiemetics are the medication classes most likely to compound QT risk.
  • Condition-based QT flags: Long QT syndrome, hypocalcemia, hypokalemia, hypomagnesemia, hypothyroidism, and hypothermia are the major clinical red flags that should change how casually you give QT-active agents.
  • Prior EKG value: An old EKG is often more informative than reflexive new testing, especially when it shows the patient's baseline QT before the current illness and medication stack.
  • Repeat-dose caution: Risk rises when patients need multiple antiemetic doses or several agents from different classes. We walk through when that should push you toward more monitoring in the chapter.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

References:

  1. Farkas J. Nausea, emesis, and antiemetics. EMCrit Project. Published August 17, 2020. Accessed July 6, 2023. https://emcrit.org/ibcc/antiemetic/
  2. Furyk JS, et al. Drugs for the treatment of nausea and vomiting in adults in the emergency department setting. Cochrane Database Syst Rev. 2015;2015(9):CD010106. Published 2015 Sep 28. PMID: 26411330
  3. Repanshek Z. Vomiting in a World Without Ondansetron Zachary Repanshek, MD FAAEM. www.youtube.com. Published 2018. Accessed July 6, 2023. https://www.youtube.com/watch?v=cewLtoKRzb0
  4. Patanwala AE, et al. Antiemetic therapy for nausea and vomiting in the emergency department. J Emerg Med. 2010;39(3):330-336. PMID: 20022195
  5. M. Camejo, et al. Rethinking Ondansetron as a First Line Agent for Nausea and Vomiting in the Setting of Abdominal Pain and Headache in the Emergency Department, Annals of Emergency Medicine, Volume 78, Issue 4, Supplement, 2021. Link
  6. Egerton-Warburton D, et al. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo. Ann Emerg Med. 2014;64(5):526-532.e1.  PMID: 24818542
  7. Braude D, et al. Antiemetics in the ED: a randomized controlled trial comparing 3 common agents. Am J Emerg Med. 2006;24(2):177-182. PMID: 16490647
  8. Cisewski D. Droperidol Use in the Emergency Department – What’s Old is New Again. emDOCs.net - Emergency Medicine Education. Published August 1, 2019. http://www.emdocs.net/droperidol-use-in-the-emergency-department-whats-old-is-new-again/
  9. Shahsavari D, et al. Haloperidol Use in the Emergency Department for Gastrointestinal Symptoms: Nausea, Vomiting, and Abdominal Pain. Clin Transl Gastroenterol. 2021;12(6):e00362. Published 2021 Jun 1.  PMID: 34060494
  10. J. McCoy, et al. Stop the Vomit: Haloperidol as a Superior First-line Antiemetic, Annals of Emergency Medicine, Volume 80, Issue 4, Supplement, 2022. Link

Faculty